바이오인

 

 

  At this year’s Systems Integration in Biodefense meeting, we will hear from industry leaders about their strategy for meeting the needs of the community and bridging the technology gaps that still exist. New assays will be introduced that are highly multiplexed, integrated and field deployable. Technology developments in sample prep, signal transduction and amplification will be showcased, and specific examples of integrated systems will be presented. Dual-use application is an essential feature for products to have utility in biodefense and clinical settings. A discussion on getting products to market and facing commercialization, collaboration, and business challenges will be addressed. The meeting will be followed by the 2nd Annual Enabling Point-of-Care Diagnostics to elucidate the transition from biodefense to a clinical setting, and the tactical issues of implementation.

  Scientific Advisory Board Steven Buchsbaum, Ph.D., Senior Program Officer, Global Health
Technologies, Bill & Melinda Gates Foundation John C. Carrano, Ph.D., Vice President, Research and Development, Luminex Corporation kenton L. Lohman, Ph.D., Senior Biotechnology Advisor, Midwest Research Institute, National Capital Region Division Lloyd J. Whitman, Ph.D., Deputy Director, Center for Nanoscale Science and Technology, National Institute of Standards and Technology